Published 2016 | Version v1

Publication Metadata-only

Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition

Creators: Cossu, Giovanni; Ceravolo, Roberto; Zibetti, Maurizio; Arca, Roberta; Ricchi, Valeria; Paribello, Alessandra; Murgia, Daniela; Merola, Aristide; Romagnolo, Alberto; Nicoletti, Valentina; Palermo, Giovanni; Mereu, Alessandra; Lopiano, Leonardo; Melis, Maurizio; Abbruzzese, Giovanni; Bonuccelli, Ubaldo

Others:: Cossu, Giovanni; Ceravolo, Roberto; Zibetti, Maurizio; Arca, Roberta; Ricchi, Valeria; Paribello, Alessandra; Murgia, Daniela; Merola, Aristide; Romagnolo, Alberto; Nicoletti, Valentina; Palermo, Giovanni; Mereu, Alessandra; Lopiano, Leonardo; Melis, Maurizio; Abbruzzese, Giovanni; Bonuccelli, Ubaldo

Description

Our purpose was to determine whether the use of catechol-O-methyltransferase-inhibitors (ICOMT) can reduce the risk of developing levodopa (LD)-induced neuropathy in Parkinson's disease (PD) patients.

Additional details

Created:: April 14, 2023
Modified:: November 28, 2023